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AbstrACt
Objectives Conflicting results have been reported when 
the associations between metabolic health, obesity and 
depression were examined previously. The primary aim 
of this study was to determine whether metabolic health 
or obesity are independently associated with depressive 
symptoms, among a representative sample of older people 
living in England. Independent associations between 
covariates and depression were also examined.
Design Prospective study with a 2‑year follow‑up.
setting The English Longitudinal Study of Ageing Wave 6 
(2012–2013) and Wave 7 (2014–2015).
Participants 6804 participants aged older than 50 years.
Data Analysis Multivariate models were used to 
determine whether metabolic health or obesity are 
independently associated with depressive symptoms 
at 2‑year follow‑up. Unadjusted and adjusted ORs with 
corresponding 95% CI were calculated; the adjusted ORs 
took account of baseline depression, gender, age, wealth, 
obesity and poor metabolic health.
results Before adjusting for covariates, poor metabolic 
health was associated with depressive symptoms at 
2‑year follow‑up (OR 1.24; 95% CI, 1.07 to 1.44, p<0.01). 
After adjusting for covariates, the association was no 
longer statistically significant (OR 1.17; 95% CI, 0.99 to 
1.38, p=0.07). Similarly, obesity was associated with 
depressive symptoms at 2‑year follow‑up before adjusting 
for covariates (OR 1.54; 95% CI, 1.33 to 1.79, p<0.01). 
However, after adjusting for covariates the association 
between obesity and depressive symptoms at 2‑year 
follow‑up became statistically insignificant (OR 1.19; 
95% CI, 1.00 to 1.41, p=0.06). The strongest predictors 
for future depression were baseline depression (OR 10.59; 
95% CI, 8.90 to 12.53, p<0.01) and lower wealth (OR 3.23; 
95% CI, 2.44 to 4.35, p<0.01).
Conclusion Neither poor metabolic health nor obesity 
were associated with a risk of depressive symptoms at 
2‑year follow‑up, after adjusting for covariates. As wealth 
inequalities continue to rise across England, the risk of 
depressive symptoms at 2‑year follow‑up is likely to be 
elevated in individuals living in the lower wealth quintiles.
IntrODuCtIOn 
Obesity and depression are significant public 
health issues in the UK. At present 26% of 
adults are classified as obese (defined as 
a body mass index of 30 kg/m2 or above), 
and this percentage is anticipated to rise 
in future years.1 Obesity is associated with 
adverse outcomes including the development 
of cardiovascular diseases, type 2 diabetes 
and other potentially life-threatening condi-
tions.2 However, further research is needed 
to determine whether obesity is associated 
with psychological conditions, particularly 
depression, because this condition is now 
the leading cause of disability and ill health 
within the UK.3
Inconsistent findings have been reported 
when the association between obesity and 
depression has been examined previously. 
Conclusions drawn from early studies 
suggested that there was no association 
strengths and limitations of this study
 ► A representative sample (n=6804) of older people 
living in England provided data for this prospective 
analysis.
 ► Standardised data collection methods and validated 
data collection tools were used to obtain data for 
the English Longitudinal Study of Ageing Wave 6 and 
Wave 7.
 ► All multivariate models were adjusted for base‑
line depression, gender, age, wealth, obesity and 
poor metabolic health to reduce the impact of 
confounders.
 ► Participants were required to truthfully and accu‑
rately recall information about their mood to prevent 
study bias.
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between obesity and depression.4 However, Crisp and 
McGuiness5 reported an inverse association between 
obesity and depression in men, while other studies have 
shown that obesity is positively associated with depressive 
symptoms in women only.6 7 Participant characteristics 
(age and gender) and sample sizes vary significantly in 
the aforementioned studies, which may offer some expla-
nation for the differing results. To address this limitation, 
a large-scale study involving a representative sample of 
the population is required.
Few studies have prospectively examined the associa-
tion between obesity and the risk of future depression, as 
previous studies have been predominantly cross-sectional.8 
Findings from the existing prospective studies were eval-
uated in a meta-analysis. Pooled ORs showed that obesity 
significantly increased an individual’s risk of developing 
depression during follow-up (OR 1.55, 95% CI; 1.22 to 
1.98, p<0.01), in both men and women.9 Meta-analytic 
data was adjusted for age and gender; however, there may 
be other confounding factors involved in this association.9
Metabolic health has been identified as a potential 
confounder in the association between obesity and the risk 
of future depression in several studies.10 11 Partial support 
for this finding is provided from analyses conducted on 
eight cohort studies.12 Jokela et al12 reported that obese 
individuals with poor metabolic health were 23% more 
likely to experience depression, compared with obese 
individuals with a favourable metabolic profile; however, 
the risk of depression for the latter group remained 
elevated when compared with non-obese individuals 
who had good metabolic health.12 Furthermore, findings 
from a prospective cohort study with 16-year follow-up 
showed that metabolic health was a better predictor of 
future depression, compared with obesity.13 No associa-
tion between metabolic health and depression has been 
reported in other studies. Various definitions of metabolic 
health exist within the literature, which may offer some 
explanation for the differing study findings; however, 
further research into the relationship between metabolic 
health, obesity and depression is required.14
The primary aim of this study was to determine whether 
metabolic health or obesity are independently associated 
with depressive symptoms at 2-year follow-up, using the 
latest data from the English Longitudinal Study of Ageing 
(ELSA). In addition, we determined whether the covari-
ates used in our analyses were independently associated 
with depressive symptoms at follow-up.
MethOD
sample and participants
A prospective study was conducted using Wave 6 and Wave 
7 data gathered from ELSA. Since inception in 2002, 
ELSA has gathered socio-economic, lifestyle and health 
data from a representative sample of the English popu-
lation, who are older than 50 years. Every 2 years, a new 
‘wave’ of ELSA data are collected.15 This study used data 
collected between 2012 and 2013 (Wave 6) as baseline 
data. Data collected between 2014 and 2015 (Wave 7) was 
used for follow-up. Overall, 6804 participants successfully 
provided data in both Wave 6 and Wave 7, and this group 
are the focus of the current study (online supplementary 
material figure 1).15
Patient and public involvement
No patients were involved in the development of the 
research question, study design or data interpretation in 
this study.
ELSA wave data are anonymised and freely accessible 
from the UK Data Service.16
Data collection
Three methods of data collection were utilised during 
ELSA Wave 6: a paper-based questionnaire, a face-to-face 
interview and a nurse interview. In Wave 7, the nurse 
interview did not take place; instead, data was collected 
during a face-to-face interview and using a paper-based 
questionnaire.
Face-to-face interviews
In both Wave 6 and Wave 7, face-to-face interviews were 
conducted by trained interviewers at the participant’s 
residential address. The interviewers recorded demo-
graphic information for each participant, in addition 
to asking the participants questions about their physical 
and mental health status. To determine whether partic-
ipants were experiencing depressive symptoms, they 
were asked to answer eight questions which had been 
adapted from the Center for Epidemiologic Studies 
Depression (CES-D) Scale.17 One point was awarded for 
each depressed answer given. Each participant received a 
total score between 0 and 8. In accordance with previous 
studies, a score ≥4 was used to define participants with 
elevated depressive symptoms.10 18
The interviewers also asked the participants to provide 
information about everyone who resided within their 
property, including information about their financial situ-
ation, employment status, assets and whether they were in 
receipt of any benefits. Participants were allocated to one 
of five wealth quintiles, with quintile 1 being the poorest 
and quintile 5 being the wealthiest. Wealth quintiles refer 
to household wealth (financial assets, physical assets and 
housing wealth) but not pension wealth.19 Wealth was 
calculated less debts and included the value of owner-oc-
cupied housing (less mortgage); all assets held in bank 
accounts in England; the value of any business properties 
or holiday homes (less mortgage) and the value of phys-
ical assets such as antiques, artwork and jewellery.20
nurse interview
Demographic information for each participant was also 
collected during the nurse interview in Wave 6. Subse-
quent stages of the nurse interview involved participants 
having their blood pressure, pulse rate, lung function 
and grip strength measured, in addition to providing 
hair samples and fasting blood samples. Fasting blood 
test results and blood pressure readings were analysed 
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to determine a participant’s metabolic health status. In 
this study, a participant with two or more metabolic risk 
factors was described as having poor metabolic health. 
The following were defined as metabolic risk factors: 
glycated haemoglobin greater than 6.0% (42 mmol/
mol); C-reactive protein greater than or equal to 3 mg/L; 
high-density lipoprotein less than 1.03 mmol/L for men 
or less than 1.30 mmol/L for women; triglycerides greater 
than or equal to 1.7 mmol/L and blood pressure readings 
greater than 130/85 mm Hg.10
The nurse interviewer also recorded a number of 
anthropometric measurements including height, weight 
and waist circumference for each participant. Using a 
participant’s weight and height values, it was possible to 
calculate their body mass index (BMI). A participant was 
classified as obese if their calculated BMI was ≥30 kg/m2.
Data analysis
Descriptive statistics were used initially to summarise the 
prevalence of depressive symptoms among participants. 
These data were subsequently stratified according to 
participant demographics and Χ2 tests were performed. 
Multivariate models were used to determine whether 
metabolic health or obesity are independently associated 
with depressive symptoms at 2-year follow-up (Wave 7). 
The minimum sample size required for our multivariate 
models was 319.21 Unadjusted and adjusted odds ratios 
with corresponding 95% CI for the risk of depressive 
symptoms at 2-year follow-up were calculated. Following 
the main analysis, a secondary analysis was conducted 
excluding cases with depressive symptoms at Wave 6. The 
following factors were covariates: baseline depression, 
gender, age, wealth, obesity and poor metabolic health. 
Missing data was coded as ‘missing’ and presented as a 
separate category in the multivariate models. All p values 
generated from the models were considered to be statisti-
cally significant if p<0.05. Analyses were undertaken using 
SPSS V.24.0.
results
Participant characteristics
Overall, 6804 participants successfully provided data in 
both Wave 6 and Wave 7. Baseline participant charac-
teristics are presented in table 1. The mean age of the 
participants was 67.6 years, 44.5% (n=3030/6804) of the 
participants were male and 12.8% (n=872/6804) of the 
participants had elevated depressive symptoms at base-
line. At follow-up (Wave 7), 12.5% (n=851/6804) of the 
participants had elevated depressive symptoms (table 1). 
Baseline data were stratified according to participant 
characteristics, including gender, age, metabolic health 
status and BMI. The prevalence of depressive symptoms 
was higher among females (15.1%), compared with males 
(9.2%) at Wave 7 (table 1). Results from the Χ2 statistical 
test showed an association between gender and depressive 
symptoms (χ2(1)=53.26, p<0.01). There was also a signif-
icant association between age and depressive symptoms 
(χ2(3)=36.24, p<0.01). A greater proportion of individuals 
with poor metabolic health (13.6%) had elevated depres-
sive symptoms at Wave 7, compared with participants with 
good metabolic health (11.2%) (table 1). The association 
between metabolic health and depressive symptoms was 
significant (χ2(1)=8.48, p<0.01). Similarly, there was a 
significant association between obesity (BMI ≥30 kg/m2) 
and depressive symptoms (χ2(2)=32.63, p<0.01).
examining the association between poor metabolic health and 
the risk of depressive symptoms at 2-year follow-up (Wave 7)
The unadjusted logistical regression analysis showed 
that participants with poor metabolic health were 24.0% 
more likely to experience depressive symptoms at 2-year 
follow-up, compared with those with good metabolic 
health. This finding was statistically significant (p<0.01) 
(table 2). The OR for the risk of depressive symptoms at 
Table 1 Wave 6 participant characteristics and associated 
depressive symptoms at Wave 7 (n=6804)
Participant characteristics
Depressive symptoms 
(Wave 7)
(Center  for 
Epidemiologic Studies 
Depression Scale 4+)
No (0–3) 
(n=5953) 
(%)
Yes (≥4)
(n=851) 
 (%)
All participants (n=6804) 87.5 12.5
Gender
  Male (n=3030) 90.8 9.2
  Female (n=3774) 84.9 15.1
Age
  50–59 years (n=1492) 85.4 14.6
  60–69 years (n=2720) 90.0 10.0
  70–84 years (n=2313) 86.6 13.4
  85+ years (n=279) 81.7 18.3
Metabolic Health
  Good metabolic health (n=3123) 88.8 11.2
  Poor metabolic health (n=3681) 86.4 13.6
Body Mass Index (BMI)
  Non-obese (BMI<30 kg/m2) (n=4737) 89.0 11.0
  Obese (BMI≥30 kg/m2) (n=2058) 84.0 16.0
  Missing BMI data (n=9)
Baseline Depression (Wave 6)
  Baseline depression (n=872) 50.8 49.2
  No baseline depression (n=5932) 92.9 7.1
Wealth
  Wealth quintile 1 (poorest) (n=1005) 76.4 23.6
  Wealth quintile 2 (n=1214) 81.7 18.3
  Wealth quintile 3 (n=1372) 88.6 11.4
  Wealth quintile 4 (n=1464) 91.4 8.6
  Wealth quintile 5 (wealthiest) (n=1619) 94.4 5.6
  Missing wealth data (n=130)
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2-year follow-up reduced to 1.17 (1.01 to 1.35, p=0.04), 
after the model was adjusted for obesity. The OR for the 
risk of depressive symptoms at 2-year follow-up was 1.19 
(1.01 to 1.40, p=0.04), after the model was adjusted for 
obesity and baseline depression (table 2). After adjusting 
for participant characteristics and baseline depression, the 
OR for the risk of depressive symptoms at 2-year follow-up 
decreased to 1.17 (0.99 to 1.38, p=0.07) (table 2). The 
latter finding was not statistically significant.
examining the association between obesity and the risk of 
depressive symptoms at 2-year follow-up (Wave 7)
The unadjusted logistical regression analysis showed that 
obese participants were 54.0% more likely to experience 
depressive symptoms at 2-year follow-up, compared with 
participants who had a BMI <30 kg/m2 (table 3). This 
finding was statistically significant (p<0.01) (table 3). The 
OR for the risk of depressive symptoms at 2-year follow-up 
reduced to 1.50 (1.29 to 1.75, p<0.01), after adjusting 
for poor metabolic health (table 3). The OR for the risk 
of depressive symptoms at 2-year follow-up decreased 
further to 1.32 (1.11 to 1.56, p<0.01), after adjustments 
for poor metabolic health and baseline depression were 
made (table 3). After adjusting for participant charac-
teristics and baseline depression the OR for the risk of 
depressive symptoms at 2-year follow-up was 1.19 (1.00 to 
1.41, p=0.06) (table 3). The latter finding was not statisti-
cally significant.
examining the associations between gender, age, wealth, 
baseline depression (Wave 6) and the risk of depressive 
symptoms at 2-year follow-up (Wave 7)
Results showed that females were 48.0% more likely to 
experience depressive symptoms at 2-year follow-up 
compared with males (table 4). This finding was statis-
tically significant (p<0.01) (table 4). The association 
between age and depression was examined. The adjusted 
OR for the risk of depressive symptoms at 2-year follow-up 
was 0.91 (0.73 to 1.13, p=0.38) in participants aged 
between 60 and 69 years (table 4). This value increased to 
1.27 (1.02 to 1.58, p=0.03) in participants aged between 
70 and 84 years (table 4). For participants older than 85 
years, the adjusted OR increased further to 1.43 (0.97 to 
2.11, p=0.07) (table 4). Most findings, in relation to age, 
were not statistically significant. The association between 
wealth and depression was also examined. The adjusted 
OR for the risk of depressive symptoms at follow-up 
reduced from 0.80 (0.63 to 1.02, p=0.07) in wealth quin-
tile 2 to 0.31 (0.23 to 0.41, p<0.01) in wealth quintile 5 
(table 4). This suggests that individuals in the higher 
wealth quintiles are less likely to experience depressive 
symptoms at 2-year follow-up, compared with individ-
uals in the lower wealth quintiles. Finally, the association 
between baseline depression and future depression was 
examined. The adjusted OR for the risk of depressive 
symptoms at 2-year follow-up was 10.59 (8.90 to 12.53, 
p<0.01).
Table 2 The association between poor metabolic health and the risk of depressive symptoms at 2-year follow-up (Wave 7) 
(n=6804)
Independent variable OR
95% CI for OR
P valueLower Upper
Metabolic health 1.24 1.07 1.44 <0.01
Metabolic health
Adjusted for obesity
1.17 1.01 1.35 0.04
Metabolic health
Adjusted for obesity and baseline depression (Wave 6)
1.19 1.01 1.40 0.04
Metabolic health
Adjusted for obesity, baseline depression (Wave 6), gender, age and wealth
1.17 0.99 1.38 0.07
Table 3 The association between obesity and the risk of depressive symptoms at 2-year follow-up (Wave 7) (n=6804)
Independent variable OR
95% CI for OR
P valueLower Upper
Obesity 1.54 1.33 1.79 <0.01
Obesity
Adjusted for poor metabolic health
1.50 1.29 1.75 <0.01
Obesity
Adjusted for poor metabolic health and baseline depression (Wave 6)
1.32 1.11 1.56 <0.01
Obesity
Adjusted for poor metabolic health, baseline depression (Wave 6), 
gender, age and wealth
1.19 1.00 1.41 0.06
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DIsCussIOn
This study evaluated the associations between metabolic 
health, obesity and depressive symptoms. Initially, the 
unadjusted logistical regression model showed that poor 
metabolic health was associated with depressive symptoms 
at 2-year follow-up; however, after adjusting for covariates, 
including baseline depression, obesity, gender, age and 
wealth, this finding was no longer statistically significant, 
and the previously elevated adjusted ORs diminished. 
Similar findings were generated when the association 
between obesity and depressive symptoms was exam-
ined. The unadjusted logistical regression model initially 
showed that obesity was associated with depressive symp-
toms at 2-year follow-up, but after adjusting for covariates, 
the finding became statistically insignificant.
Our findings are different to those reported in previous 
studies. Studies which report an association between meta-
bolic health, obesity and depression often attribute the 
association to biological changes. For example, obesity is 
commonly associated with metabolic abnormalities such 
as insulin resistance and raised inflammatory markers, 
and previous research has shown that these abnormali-
ties are independently associated with the development 
of depression.22–24 Another explanation offered for the 
association is that poor metabolic health and obesity have 
both been linked to a reduction in serotonergic activity 
in the brain, thus increasing the likelihood of depres-
sion.25 26 However, the biological mechanisms underlying 
the association are complex and not fully understood.
To our knowledge, only one prospective study has been 
conducted previously to determine ‘whether the associ-
ation of obesity with depressive symptoms is dependent 
on the individual’s metabolic health’, using ELSA data.10 
Hamer et al10 created four participant models: ‘meta-
bolically healthy non-obese’, ‘metabolically unhealthy 
non-obese’, ‘metabolically healthy obese’ and ‘meta-
bolically unhealthy obese’. Using participants in the 
‘metabolically healthy non-obese’ group as controls, 
the adjusted ORs showed that ‘metabolically unhealthy 
obese’ participants were 50% more likely to experience 
depression at follow-up. For ‘metabolically unhealthy 
non-obese’ participants, the likelihood of experiencing 
depression at follow-up was 44%. This value reduced 
to 38% for ‘metabolically healthy obese’ participants.10 
Based on their findings, the authors concluded that 
‘the association between obesity and risk of depression 
symptoms appears to be partly dependent on metabolic 
health’.10 However, in this study, we found that neither 
poor metabolic health nor obesity are associated with 
a risk of depressive symptoms at 2-year follow-up. It 
is possible that a period effect may have contributed 
towards the differing findings because Hamer et al10 
analysed ELSA data gathered between 2004 and 2007, 
and this study analysed ELSA data gathered between 
2012 to 2015; however, the time frame between the 
two studies is relatively short.27 Another possible expla-
nation for the differing findings is that Hamer et al10 
identified medical factors as confounders, whereas this 
Table 4 The association between the independent variables and the risk of depressive symptoms at 2-year follow-up (Wave 
7) (n=6804)
Independent variables Adjusted OR
95% CI for OR
P valueLower Upper
Gender
  Male (Reference) (n=3030) 1
  Female (n=3774) 1.48 1.25 1.75 <0.01
Age
  50–59 years (Reference) (n=1492) 1
  60–69 years (n=2720) 0.91 0.73 1.13 0.38
  70–84 years (n=2313) 1.27 1.02 1.58 0.03
  85+ years (n=279) 1.43 0.97 2.11 0.07
Wealth
  Wealth quintile 1 (poorest) (Reference) (n=1005) 1
  Wealth quintile 2 (n=1214) 0.80 0.63 1.02 0.07
  Wealth quintile 3 (n=1372) 0.50 0.39 0.64 <0.01
  Wealth quintile 4 (n=1464) 0.43 0.33 0.56 <0.01
  Wealth quintile 5 (wealthiest) (n=1619) 0.31 0.23 0.41 <0.01
  Missing wealth data (n=130)
Baseline depression (Wave 6)
  Baseline depression (n=872) 10.59 8.90 12.53 <0.01
  No baseline depression (n=5932)
Adjusted for obesity, poor metabolic health, baseline depression (Wave 6), gender, age and wealth.
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study included wealth, in addition to medical factors as 
confounders.
This study shows that lower wealth, along with baseline 
depression, are strong predictors for the risk of depres-
sive symptoms at 2-year follow-up. Patten et al28 support 
our wealth finding, concluding that an increased prev-
alence of major depression was associated with lower 
personal wealth. Similarly, Martikainen et al29 analysed 
data collected during the Whitehall II study and reported 
that depression was most common among individuals in 
the lowest wealth categories, after adjusting for age and 
ill health at baseline. This finding is important because 
wealth inequalities are continuing to rise across England; 
therefore, the risk of experiencing depressive symptoms 
at 2-year follow-up is likely to be elevated in individuals 
living in the lower wealth quintiles.30
Our multivariate model was also used to determine 
whether gender or age were independently associated with 
a risk of depressive symptoms at 2-year follow-up. Find-
ings showed that females were more likely to experience 
depressive symptoms at 2-year follow-up compared with 
males. This finding was statistically significant (p<0.01) 
and consistent with the existing literature.31–33 Albert31 
suggests that ‘biological sex differences’ are fundamen-
tally responsible for the differing prevalence of depression 
between males and females, but the author also acknowl-
edges that further research is necessary to develop our 
understanding about this complex finding. While a crit-
ical review by Piccinelli and Wilkinson33 identified that 
a lack of social integration, reduced social support and 
an increased vulnerability to adverse life events were 
social factors, which may potentially contribute towards a 
higher incidence of depression among females.
Individuals older than 70 years were at least 27.0% 
more likely to experience depressive symptoms at 
2-year follow-up compared with individuals aged 
between 50 and 59 years. Findings also showed that 
participants aged between 60 and 69 years were 9.0% 
less likely to experience depressive symptoms at 2-year 
follow-up, compared with individuals aged between 50 
and 59 years. This U-shaped curve in depression prev-
alence has been reported previously by Blanchflower 
and Oswald.34 An explanation for this finding could 
be that retirement is beneficial for an individual’s 
mental well-being.35
The size and representativeness of our sample are 
the primary strengths of this study, and therefore, 
our findings are generalisable to the English popu-
lation, who are aged over 50 years. Standardised data 
collection methods and validated data collection 
tools were used to obtain data for ELSA, for example 
the CES-D was used to gather data about depressive 
symptoms. The CES-D scale requires participants to 
accurately and truthfully recall information about 
their depressive symptoms to prevent study bias.36 
The cause of depressive symptoms is often multifac-
torial, and although many covariates were used in the 
analyses to minimise study bias, there may be other 
contributory factors which have not been examined in 
ELSA, and thus, these factors could have influenced 
our findings. While this study indicated that neither 
metabolic health nor obesity predict depressive symp-
toms at 2-year follow-up, there could nevertheless be 
associations which are obscured by the study design. 
As the study only included respondents aged older 
than 50 years, it is possible that metabolic health and/
or obesity could predict depression earlier in the life 
course.
COnClusIOn
This study has identified that neither poor metabolic 
health nor obesity are associated with a risk of depressive 
symptoms at 2-year follow-up. Findings from this study 
also showed that baseline depression and lower wealth 
are strong predictors for the risk of depressive symptoms 
at 2-year follow-up. Previous research has predominantly 
identified medical factors as confounders; however, this 
study highlights the importance of considering wealth, 
in addition to medical factors, as confounders in future 
research.
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